Marcio Fonseca - Acacia Pharma Director
Director
Mr. Marcio Bastos Fonseca serves as Director of the Company. Mr. Fonseca is a professional geologist and received a master of mineral project appraisal, an MSc, from Imperial College, London since 2017.
| Tenure | 7 years |
| Phone | 44 1223 919760 |
| Web | https://www.acaciapharma.com |
Acacia Pharma Management Efficiency
The company has return on total asset (ROA) of (40.36) % which means that it has lost $40.36 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (155.35) %, meaning that it generated substantial loss on money invested by shareholders. Acacia Pharma's management efficiency ratios could be used to measure how well Acacia Pharma manages its routine affairs as well as how well it operates its assets and liabilities.The company has accumulated 28.02 M in total debt with debt to equity ratio (D/E) of 1.08, which is about average as compared to similar companies. Acacia Pharma Group has a current ratio of 3.71, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Acacia Pharma until it has trouble settling it off, either with new capital or with free cash flow. So, Acacia Pharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Acacia Pharma Group sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Acacia to invest in growth at high rates of return. When we think about Acacia Pharma's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Lee Mitchell | National CineMedia | 81 | |
| Jeremy Levine | 46 | ||
| Michelle Wilson | 57 | ||
| Mark Segall | National CineMedia | 55 | |
| Michael Splinter | Taiwan Semiconductor Manufactur | 70 | |
| Dan Dorenkamp | National CineMedia | N/A | |
| Meiling Chen | Taiwan Semiconductor Manufactur | N/A | |
| Jeffrey Jordan | 61 | ||
| Stan Shih | Taiwan Semiconductor Manufactur | N/A | |
| Thomas Engibous | Taiwan Semiconductor Manufactur | 61 | |
| Craig Ramsey | National CineMedia | 63 | |
| Zhizhuang Zou | Taiwan Semiconductor Manufactur | N/A | |
| Kurt Hall | National CineMedia | 58 | |
| Zhongxi Li | Taiwan Semiconductor Manufactur | N/A | |
| Zhenrong Shi | Taiwan Semiconductor Manufactur | N/A | |
| Stephen Lanning | National CineMedia | 62 | |
| Andrea Wishom | 50 | ||
| David Haas | National CineMedia | 76 | |
| Leslie Kilgore | 54 | ||
| Andrew Glaze | National CineMedia | 39 | |
| Evan Sharp | 41 | ||
Management Performance
| Return On Equity | -155.35 | |||
| Return On Asset | -40.36 |
Acacia Pharma Group Leadership Team
Elected by the shareholders, the Acacia Pharma's board of directors comprises two types of representatives: Acacia Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Acacia. The board's role is to monitor Acacia Pharma's management team and ensure that shareholders' interests are well served. Acacia Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Acacia Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Paul Champagne, Independent Director | ||
| Thomas Pladsen, CFO and Secretary | ||
| Albrecht Schneider, Executive Chairman and Member of Environmental, Health and Safety Committee | ||
| Scott Caldwell, Independent Director | ||
| Carl Hansen, CEO and President and Director | ||
| Marcio Fonseca, Director | ||
| Antonio Ortuzar, Director |
Acacia Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Acacia Pharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -155.35 | |||
| Return On Asset | -40.36 | |||
| Current Valuation | 101.08 M | |||
| Shares Outstanding | 83.9 M | |||
| Shares Owned By Insiders | 20.69 % | |||
| Shares Owned By Institutions | 35.54 % | |||
| Price To Earning | (24.17) X | |||
| Price To Book | 1.34 X | |||
| Price To Sales | 72.33 X | |||
| Revenue | 1.16 M |
Pair Trading with Acacia Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Acacia Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acacia Pharma will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Xcel Energy could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Xcel Energy when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Xcel Energy - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Xcel Energy to buy it.
The correlation of Xcel Energy is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Xcel Energy moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Xcel Energy moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Xcel Energy can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Acacia Pharma Group information on this page should be used as a complementary analysis to other Acacia Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in Acacia Pink Sheet
If you are still planning to invest in Acacia Pharma Group check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acacia Pharma's history and understand the potential risks before investing.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |